{"id":3197,"date":"2025-11-06T15:34:37","date_gmt":"2025-11-06T14:34:37","guid":{"rendered":"https:\/\/www.lagitre.com\/conclusa-con-successo-la-prima-demo-in-italia-del-kit-one-lambda-hybritype-hla-plus-typing-flex\/"},"modified":"2026-03-30T15:57:29","modified_gmt":"2026-03-30T14:57:29","slug":"conclusa-con-successo-la-prima-demo-in-italia-del-kit-one-lambda-hybritype-hla-plus-typing-flex","status":"publish","type":"post","link":"https:\/\/www.lagitre.com\/en\/conclusa-con-successo-la-prima-demo-in-italia-del-kit-one-lambda-hybritype-hla-plus-typing-flex\/","title":{"rendered":"First Demo in Italy of the One Lambda\u2122 HybriType\u2122 HLA Plus Typing Flex Kit Successfully Completed"},"content":{"rendered":"<p>The first demonstration in Italy of the One Lambda\u2122 HybriType\u2122 HLA Plus Typing Flex kit has been successfully completed. This new NGS solution enables 11-loci HLA typing through hybrid capture technology, with a fast and streamlined workflow.<br \/>\nDuring the demo, the additional panel for 7 non-classical HLA loci and the optional ABO panel were also tested, allowing for a comprehensive evaluation of the product\u2019s capabilities.<br \/>\nLagitre\u2019s Field Application Specialists, Giuseppe Tortorici and Valentina Vigan\u00f2, supported by the One Lambda \u2013 A Thermo Fisher Scientific Brand team, led the sessions, which concluded with excellent results and a high level of satisfaction among all participants.<br \/>\nWith this new NGS solution\u2014soon to be CE-IVDR marked\u2014Lagitre further strengthens its molecular portfolio, expanding the range of solutions available to support the needs of HLA laboratories and looking ahead with enthusiasm to a future full of new and exciting opportunities.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The first demonstration in Italy of the One Lambda\u2122 HybriType\u2122 HLA Plus Typing Flex kit has been successfully completed. This new NGS solution enables 11-loci HLA typing through hybrid capture technology, with a fast and streamlined workflow. During the demo, the additional panel for 7 non-classical HLA loci and the optional ABO panel were also [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3196,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[],"class_list":["post-3197","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-eng"],"_links":{"self":[{"href":"https:\/\/www.lagitre.com\/en\/wp-json\/wp\/v2\/posts\/3197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lagitre.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lagitre.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lagitre.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lagitre.com\/en\/wp-json\/wp\/v2\/comments?post=3197"}],"version-history":[{"count":2,"href":"https:\/\/www.lagitre.com\/en\/wp-json\/wp\/v2\/posts\/3197\/revisions"}],"predecessor-version":[{"id":3455,"href":"https:\/\/www.lagitre.com\/en\/wp-json\/wp\/v2\/posts\/3197\/revisions\/3455"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lagitre.com\/en\/wp-json\/wp\/v2\/media\/3196"}],"wp:attachment":[{"href":"https:\/\/www.lagitre.com\/en\/wp-json\/wp\/v2\/media?parent=3197"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lagitre.com\/en\/wp-json\/wp\/v2\/categories?post=3197"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lagitre.com\/en\/wp-json\/wp\/v2\/tags?post=3197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}